You are here » Home » Companies » Company Overview » Bharat Immunological & Biological Corporation Ltd

Bharat Immunological & Biological Corporation Ltd.

BSE: 524663 Sector: Health care
NSE: N.A. ISIN Code: INE994B01014
BSE 00:00 | 02 Jun 17.15 -0.35
(-2.00%)
OPEN

17.15

HIGH

17.15

LOW

17.15

NSE 05:30 | 01 Jan Bharat Immunological & Biological Corporation Ltd
OPEN 17.15
PREVIOUS CLOSE 17.50
VOLUME 5816
52-Week high 20.80
52-Week low 5.41
P/E
Mkt Cap.(Rs cr) 74
Buy Price 17.50
Buy Qty 51.00
Sell Price 17.15
Sell Qty 382486.00
OPEN 17.15
CLOSE 17.50
VOLUME 5816
52-Week high 20.80
52-Week low 5.41
P/E
Mkt Cap.(Rs cr) 74
Buy Price 17.50
Buy Qty 51.00
Sell Price 17.15
Sell Qty 382486.00

Bharat Immunological & Biological Corporation Ltd. (BHARATIMMUNOLOG) - Company History

Incorporated in 1989 in Uttar Pradesh, Bharat Immunological & Biological Corporation (BIBCL) is in the business of manufacturing pharmaceutical formulations. The company's manufacturing unit is located in Bulandshahr district, Uttar Pradesh. BIBCL manufactures oral polio vaccine (OPV) for which it has installed a plant of 100 mln units. Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme. It has set up an R&D unit for the development of hepatitis B vaccine through transfer of technology from the US. The Company is planning to diversify into the production of vaccines pertaining to B.C.G, Measles and Tetanus Toxide.The company has been declared a SICK company by BIFR.